IMW 2019 | Myeloma prognosis – the emergence of MRD

Bruno Paiva

Bruno Paiva, PhD from the University of Navarra Clinic, Pamplona, Spain, describes the emergence of measurable residual disease (MRD) in determining the prognosis of multiple myeloma. Dr Paiva was speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video